Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens

European Journal of Pharmacology

Volumn 503, Issue 1-3, 2004, Pages 191-201

  Caricati Neto, Afonso ^a   D'Angelo, Luiz Carlos Abech ^a   Reuter, Haydee ^a   Hyppolito Jurkiewicz, Neide ^a   G Garcia, Antonio ^b,c   Jurkiewicz, Aron ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fac Med Univ Auton M   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

Galantamine; Purinergic neurotransmission; Vas deferens

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; NICOTINIC RECEPTOR; PHYSOSTIGMINE; RIVASTIGMINE; TACRINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; ELECTROSTIMULATION; NEUROTRANSMISSION; NONHUMAN; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; VAS DEFERENS;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; CHOLINESTERASE INHIBITORS; DRUG SYNERGISM; ELECTRIC STIMULATION; GALANTAMINE; INDANS; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; NICOTINE; NICOTINIC AGONISTS; PHENYLCARBAMATES; PHYSOSTIGMINE; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC; STIMULATION, CHEMICAL; SYNAPTIC TRANSMISSION; TACRINE; VAS DEFERENS;

EID: 7444239678     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.09.034     Document Type: Article

References (41)

1. E. Alés, E. Arias, A.G. Garcia, and M.G. Lopez Galantamine induces neurotransmitter release likely by blocking SK channels: a new mechanism of action for anti-Alzheimer's drugs Methods Find. Exp. Clin. Pharmacol. 24 2002 151 162
2. F. Arnal, L.J. Cote, S. Ginsburg, G.D. Lawrence, A. Naini, and M. Sano Studies on new, centrally active and reversible acetylcholinesterase inhibitors Neurochem. Res. 15 1990 587 591
3. + channels in bovine chromaffin cells Pflugers Arch. Eur. J. Physiol. 423 1993 97 103
4. G. Burnstock The changing face of autonomic neurotransmission Acta Physiol. Scand. 126 1986 67 91
5. G. Burnstock The fifth Heymans memorial lecture co-transmission Arch. Int. Pharmacodyn. 304 1990 7 33
6. G. Burnstock Noradrenaline and ATP: cotransmitters and neuromodulators J. Physiol. Pharmacol. 46 1995 365 384
7. A. Caricati-Neto, M. Sette, and A. Jurkiewicz Increased density of α-adrenoceptors in vas deferens of spontaneously hypertensive rats (SHR), indicated by functional and receptor binding studies Eur. J. Pharmacol. 218 1992 51 58
8. R.C. Carneiro, and R.P. Markus Prejunctional nicotinic receptors involved in release of noradrenaline and ATP from the prostatic portion of the rat vas deferens J. Pharmacol. Exp. Ther. 255 1990 95 100
9. C.F.J. Castillo, S. Lafayette, A. Caricati-Neto, M. Sette, N.H. Jurkiewicz, A.G. Garcia, and A. Jurkiewicz Low dihydropyridine receptor density in vasa deferentia of castrated rats Br. J. Pharmacol. 105 1992 257 258
10. J. Coyle, and P. Kershaw Galantamine, a cholinesterase inhibitor that allosterically modulates nicotinic receptors: effects on the course of Alzheimer's disease Biol. Psychiatry 49 2001 289 299
11. + channels blockers in rat vas deferens Eur. J. Pharmacol. 287 1995 287 293
12. 2-adrenoceptor-mediated modulation in guinea-pig vas deferens Naunyn-Schmiedeberg's Arch. Pharmacol. 348 1993 358 366
13. G.L. Ellman, K.D. Courtney, V. Andres, and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
14. A. Enz, H. Boddeke, J. Gray, and R. Spiegel Pharmacologic and clinicopharmacologic properties of SDZ ENA 713, a centrally selective acetylcholinesterase inhibitor Ann. N.Y. Acad. Sci. 640 1991 272 275
15. H. Feldman, S. Gauthier, J. Hecker, B. Vellas, P. Subbiah, and E. Wholen A 24-week randomized, double blind study of donepezil in moderate to severe Alzheimer's disease Neurology 57 2001 613 620
16. E. Giacobini, R. Spiegel, A. Enz, A.E. Veroff, and N.R. Cutler Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit J. Neural Transm. 109 2002 1053 1065
17. J.A. Gosling, and J.S. Dixon Differences in the manner of autonomic innervation of the muscle layers of the guinea-pig ductus deferens J. Anat. 112 1972 81 91
18. M.I. Harhun, A. Jurkiewicz, N.H. Jurkiewicz, D.O. Krysthtal, M.F. Shuba, and I.A. Vladimirova Voltage-gated potassium currents in rat vas deferens smooth muscle cells Eur. J. Phys. 446 2003 380 386
19. A. Jurkiewicz, and N.H. Jurkiewicz Dual effect of alpha-adrenoceptor antagonists in rat isolated vas deferens Br. J. Pharmacol. 56 1976 169 172
20. A. Jurkiewicz, N.H. Jurkiewicz, G.G. Barros, and J.R. Valle Relative responsiveness (ρ): of pharmacological receptor systems in the rat vas deferens Pharmacology 2 1969 89 99
21. A. Jurkiewicz, A.O. Abdo, N.H. Jurkiewicz, A.O. Guedes, and C. Souccar Relative responsiveness (ρ): a critical analysis of a new method in receptor differentiation Gen. Pharmacol. 7 1976 93 101
22. S.M. Kirpekar, A.G. Garcia, and J.C. Prat Action of nicotine on sympathetic nerve terminals J. Pharmacol. Exp. Ther. 213 1980 133 138
23. A. Maelicke, A. Schrattenholz, M. Samochocki, M. Radina, and E.X. Albuquerque Allosterically potentiating ligands of nicotinic receptors a treatment strategy for Alzheimer's disease Behav. Brain Res. 113 2000 199 206
24. H.F. Miranda, E. Duran, D. Bustamante, C. Paeile, and G. Pinardi Pre- and postjunctional muscarinic receptor subtypes in the vas deferens of rat Gen. Pharmacol. 25 1994 1643 1647
25. H.F. Miranda, E. Duran, E. Fernandez, and G. Pinardi Muscarinic receptor subtypes in the bisected vas deferens of the rat Gen. Pharmacol. 26 1995 387 391
26. V.M. Mutafova-Yambolieva, I.V. Yamboliev, and D.N. Mihailova Comparative effects of the anticholinesterase drug galantamine on the mechanical activity of isolated rat jejunum and ileum Gen. Pharmacol. 24 1993 1253 1256
27. H. Ogura, T. Kosaka, Y. Kuriya, and Y. Yamanishi Comparison of inhibitory activities of donepezil and other cholinesterase inhibitors on acetylcholinesterase and butyrilcholonesterase in vitro Methods Find. Exp. Clin. Pharmacol. 22 2000 609 613
28. E.K. Perry, V. Haroutunian, K.L. Davis, R. Levy, P. Lantos, S. Eagger, R.M. Honavar, A. Dean, M. Griffiths, and J.G. McKeith Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease NeuroReport 5 1994 747 749
29. Z. Rakonczay, and J. Kovacs Cholinesterases in Alzheimer's disease and cholinesterase inhibitors in Alzheimer's therapy Acta Biol. Hung. 49 1998 55 70
30. P.M. Robinson A cholinergic component in the innervation of the longitudinal smooth muscle of the guinea-pig vas deferens: the fine structural localization of acetylcholinesterase J. Cell Biol. 41 1969 462 476
31. G.C. Rodhe, E. Venezian, and J.P. Huidobro-Toro Assimetric distribution of purinergic and adrenergic neurotransmission cooperates in the motor activity along the rat vas deferens Neurosci. Lett. 71 1986 197 202
32. + currents in neurones: types, physiological roles and modulation TINS 19 1996 150 154
33. M.D. Santos, M. Alkondon, E.F. Pereira, Y. Aracava, H.M. Eisenberg, A. Maelicke, and E.X. Albuquerque The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system Mol. Pharmacol. 61 2002 1222 1234
34. N.O. Sjostrand Smooth muscle of vas deferens and other organs in the male reproductive tract E. Bulbring A. Branding A. Jones T. Tomita Smooth Muscle 1981 Academic Press New York 367 376
35. A.R.M. Souza Brito, and A. Jurkiewicz Some pharmacological properties of the circular smooth muscle layer of the rat vas deferens J. Pharm. Pharmacol. 40 1988 781 786
36. K. Starke, R. Bultmann, and J.R. Bulloch Noradrenaline-ATP corelease and cotransmission following activation of nicotinic receptors at postganglionic sympathetic axons J. Neural Transm. Suppl. 34 1991 93 98
37. W.K. Summers, J.O. Viesselman, G.M. Marsh, and K. Candelora Use of THA in treatment of Alzheimer's like dementia: pilot study in twelve patients Biol. Psychiatry 16 1981 145 153
38. X.C. Tang Huperzine A (shuangyiping): a promising drug for Alzheimer's disease Zhongguo Yao Xuebao 17 1996 481 484
39. I. Todorov, K. Windisch, H. Shersen, A. Lajtha, M. Papasova, and E.S. Vizi Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked noradrenaline release from the vas deferens of the guinea-pig Br. J. Pharmacol. 102 1991 186 190
40. I. Vladimirova, N.H. Jurkiewicz, and A. Jurkiewicz Evidence for participation of nitric oxide in excitatory neurotransmitter in rat vas deferens Life Sci. 55 1994 1123 1128
41. A.R. Wakade, A.G. Garcia, and S.M. Kirpekar Effect of castration on the smooth muscle cells of the internal sex organs of the rat: influence of the smooth muscle on the sympathetic neurons innervating the vas deferens, seminal vesicle and coagulating gland J. Pharmacol. Exp. Ther. 193 1975 424 434